Stay updated on CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial
Sign up to get notified when there's something new on the CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial page.

Latest updates to the CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial page
- Check4 days agoChange DetectedThe study record shows a new Recruiting status and the addition of core sections (Study Status, Contacts/Locations, Eligibility, Outcome Measures, Arms and Interventions, Study Description, Study Identification, Recruitment Status) with dates 2026-02-14 to 2026-02-20. The prior note 'Awaiting amendment to add new cohort' was removed.SummaryDifference0.4%

- Check11 days agoChange DetectedA new site revision v3.4.2 was added to the history and the previous revision v3.4.1 was removed.SummaryDifference0.0%

- Check19 days agoChange DetectedA new Study Status section was added with multiple entries, and the site revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check19 days agoChange DetectedOn 2026-02-03 a new Study Status entry was added and the site revision updated to v3.4.1 (replacing v3.4.0); earlier version entries 288–291 were recorded.SummaryDifference0.2%

- Check27 days agoChange DetectedThe history page now includes a glossary toggle, green highlights for additions and red highlights for deletions, and a new revision entry (Revision: v3.4.0, 2026-01-28); the No FEAR Act data was removed and the older revision v3.3.4 was superseded. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check34 days agoChange DetectedNew history entries were added for 2026-01-21, 2026-01-20, 2026-01-16, and 2026-01-15 documenting updates to the Study Status.SummaryDifference0.2%

Stay in the know with updates to CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD22-Positive ALL Treatment: Inotuzumab vs Blinatumomab Clinical Trial page.